KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$14.5 million.

  • Guardant Health's Change in Receivables fell 1992.04% to -$14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.7 million, marking a year-over-year increase of 838622.75%. This contributed to the annual value of $21.4 million for FY2024, which is 35529.96% up from last year.
  • Latest data reveals that Guardant Health reported Change in Receivables of -$14.5 million as of Q3 2025, which was down 1992.04% from $14.3 million recorded in Q2 2025.
  • Guardant Health's 5-year Change in Receivables high stood at $36.9 million for Q4 2021, and its period low was -$14.5 million during Q3 2025.
  • Moreover, its 5-year median value for Change in Receivables was $2.3 million (2023), whereas its average is $3.3 million.
  • In the last 5 years, Guardant Health's Change in Receivables plummeted by 303854.75% in 2021 and then surged by 12068333.33% in 2024.
  • Quarter analysis of 5 years shows Guardant Health's Change in Receivables stood at $36.9 million in 2021, then crashed by 70.04% to $11.1 million in 2022, then plummeted by 100.16% to -$18000.0 in 2023, then surged by 120683.33% to $21.7 million in 2024, then plummeted by 166.59% to -$14.5 million in 2025.
  • Its last three reported values are -$14.5 million in Q3 2025, $14.3 million for Q2 2025, and $6.1 million during Q1 2025.